Yearend 'Victory' lap: DOJ snares 2 drug makers in kickback schemes
This article was originally published in Scrip
Drug makers paying out millions of dollars to resolve state and federal civil and criminal charges stemming from accusations from insider whistleblowers has become an almost routine occurrence in the US, with two more such cases settled with the Department of Justice (DOJ) in the past week – one even involving allegations of illegal kickbacks paid to a physician in the form of strip club "lap dances" for the doctor's employees in exchange for prescribing the company's medicine.
You may also be interested in...
With new funding in hand, Moderna and its infectious disease venture Valera are going full-speed ahead with a Zika vaccine, taking an mRNA approach, which they said could be a more rapid strategy to try to stop the disease.
Allergan CEO Brent Saunders vows not to engage in price gouging and says his firm will limit cost increases to single-digit percentages, occurring only once per year. But it's unclear whether Saunders will stand as a lone wolf in the industry or if others will make similar pledges.
Hillary Clinton's plan to rein in high prices of older medicines, which includes creating a federal panel that has authority to impose fines, may grab headlines, but some analysts think it's unlikely to get very far in a divided Washington.